Skip to content
Home » Sample Page » Upcoming Clinical Trials: OSA

Upcoming Clinical Trials: OSA

Obstructive Sleep Apnoea and atrial fibrillation: The Effect of Treatment of Sleep Apnoea on Atrial Fibrillation Burden

SYNOPSIS OF THE STUDY:

  • The study aims to investigate the impact of OSA treatment on AF utilising a randomised controlled trial design.
  • Hypothesis: treatment of sleep apnoea will reduce the burden/recurrence of atrial fibrillation.
  • Primary endpoint: time to AF recurrence following AF ablation at 12 month
  • Secondary endpoint: single procedure freedom from AF recurrence at 24 months, multi-procedure AF recurrence at 12 and 24 months and reduction of AF burden

INCLUSION CRITERIA:

  • Has atrial fibrillation
  • Moderate to servere obstructive sleep apnoea as AHI > or = 15
  • Over 18yrs olf
  • Able and willing to provide informed consent and comply with all the testing and requirements

EXCLUSION CRITERIA:

  • Has valvular heart disease
  • Has AF due to trasient or reversible cause ie. post operative cardiac or non-cardiac surgery lung disease, hyperthyroidism